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N E W S L E T T E R
BRAIN DEATH, ETHICS COMMITTEES 
 & COURTS
The case of 13 year old Jahi McMath 
has been widely reported in the media. 
Jahi had her tonsils, adenoids, and extra 
sinus tissue removed on December 9, 
2013 to treat sleep apnea. She suffered 
a hemorrhage and subsequent cardiac 
arrest and was pronounced brain dead 
in a California hospital on December 
12, 2013. However, her parents sought 
court intervention to continue ventilator 
support and tube feedings as they hoped 
for a miracle to bring her back to life. 
This case raises questions about how 
far we should go to assuage the grief of 
bereaved family members when a patient 
has died.
For decades in the U.S. and other 
countries, a person who is pronounced 
dead by neurologic criteria (i.e., 
“brain dead” – no response to pain, no 
cranial nerve reflexes, no spontaneous 
respirations) is considered legally 
dead. This allows for organs of the 
deceased to be donated, death rituals to 
be enacted, and medical resources to be 
freed up for other patients who stand to 
benefit. Family members are generally 
provided a short period of time to “say 
goodbye” before medical interventions 
(e.g., ventilator, intravenous fluids or 
tube feedings) are stopped. This usually 
occurs within hours of the brain death 
diagnosis. The McMath case is unusual 
in that the family requested that Jahi 
continue to receive medical technologies 
after being pronounced dead, and a judge 
granted that request. 
How might you handle such a case if 
it came before your ethics committee? 
While patients are routinely pronounced 
dead by neurologic criteria at acute 
care hospitals, it’s a rare event for a 
child undergoing routine surgery to 
die. Questions about usual surgical risk 
versus medical error are likely to come 
up, and thus it would be appropriate to 
involve risk management. If medical 
error may have contributed to the 
patient’s death, staff should implement 
standard protocols for error disclosure 
(Bell et al., 2010; Petronio et al., 2013; 
ToughTalk, n.d.). All hospitals in 
Maryland are required to have a patient 
safety program in place that, among 
other things: identifies, assesses and 
responds to near-misses and adverse 
events relating to patient care; conducts 
root cause analyses; and reports required 
information to the Maryland Department 
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of Health and Mental Hygiene (Md. 
Code Ann. 2013). 
It may be tempting in such cases 
to defer to loved ones to “give them 
as much time as they need” to grieve 
before stopping medical technology, 
but this would run counter to the 
principle of justice in ethics that 
requires “treating like cases alike.” 
Furthermore, while hospice and 
palliative care providers often report 
implementing certain interventions 
more to benefit the dying patient’s 
family members than the patient, 
the point at which a dead body is 
subjected to medical technology 
intended only for the living purely 
to ease the grief of the family raises 
the concern of disrespecting the body 
by using it solely as a means to the 
family members’ emotional ends. How 
family members are respected and 
emotionally supported to minimize 
their regrets and assist in their grieving 
process is pivotal. However, the 
assumption that “doing whatever 
the family asks” is the best way to 
provide such support is untested, and 
thus should be challenged. Death of 
a loved one is often met by anguish 
and demands from the bereaved to 
“do everything,” but sometimes it is 
human compassion and connection, 
rather than medical technology, that is 
required to help heal a broken heart. 
Can there be another interpretation 
of “doing everything” in such 
cases? What might this look like in 
the context of ethics consultation? 
Ethics consultants called in on such 
a case should facilitate meaningful 
communication among those involved 
to ensure that the staff’s empathy 
and regret have been expressed to 
the family, that the accuracy of the 
diagnosis of brain death has been 
clearly explained, and that the parents’ 
concerns are heard. Assuming that best 
efforts are undertaken to communicate 
effectively with the parents and to 
establish trust and provide emotional 
support, and yet the parents continue 
to insist that the ventilator and tube 
feedings be maintained indefinitely, it 
would be appropriate to recommend 
that the hospital set a date to stop 
the ventilator and tube feedings 
according to the medical standard 
of care. Stopping a ventilator after 
pronouncing death is a routine 
medical procedure, and thus not 
typically handled as a certification of 
medically ineffective treatment under 
Maryland’s Health Care Decisions 
Act (HCDA). However, whether or 
not the process defined in Maryland’s 
HCDA is followed, the parents have 
a right to pursue court intervention. 
This is an appropriate due process 
“check and balance” that helps protect 
the rights of those low in the power 
hierarchy. Unfortunately, not all judges 
are equally versed in bioethics, and 
thus it would be important for the 
ethics committee to include sufficient 
background and justification to support 
Brain Death 
Cont. from page 1
Faculty from Union Graduate College-Icahn School of Medicine 
at Mount Sinai Bioethics Program have introduced a novel, 
asynchronous "online symposium" on the McMath and Munoz cases 
on their program's blog. The McMath case is featured in this issue's 
lead article. The Munoz case involved a pregnant Texas woman 
whose body was maintained on a ventilator, with artificial nutrition/
hydration, against her family's wishes, based on the hospital's 
interpretation of Texas law. These cases raise questions about the 
role of court involvement in end-of-life decision-making, particularly 
regarding determinations of brain death. Access the symposium by 
searching "McMath Munoz online symposium" in Google.
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MOLST CONFERENCE FOCUSES ON SUCCESSES 
 AND CHALLENGES
On December 9, 2013, MHECN 
and Harbor Hospital co-sponsored 
the conference, Maryland Medical 
Orders for Life-sustaining Treatment 
(MOLST): A six month check-up, 
at the UM Carey School of Law. 
The focus of the conference was on 
successes and challenges encountered 
in implementing the MOLST form in 
Maryland healthcare facilities. 
Anonymous online survey data 
presented at the conference revealed 
reasons for both satisfaction and 
dissatisfaction with the MOLST 
form. Satisfied users pointed to the 
form being completed correctly at 
their institution (e.g., the form is on 
patients’ charts and sent out with 
transfers), and the form actually 
improving patient care (e.g., by 
opening up dialogue with patients 
and family about end of life issues, 
increasing awareness of assigning a 
health care agent or completing an 
advance directive, and helping avoid 
unwanted and 
unnecessary 
medical care). 
The satisfied 
users tended to 
report having a 
process in place 
at their facility to 
ensure successful 
MOLST 
implementation 
(e.g., educating 
all parties on 
the process, 
getting buy-in 
from administration to hold clinicians 
accountable for completing MOLST 
forms on the initial visit to the facility, 
and replacing the system Do-Not-
Attempt-Resuscitation order with the 
MOLST form).
Dissatisfied users identified 
problems with how clinicians 
completed the form (e.g., the wrong 
or no decision-maker was identified, 
the form was not signed, conflicting 
preferences selected such as “palliative 
care” on page 1 but “do everything” 
on p. 2, and the form was not sent with 
the patient when it should have been). 
In addition, they identified instances 
where (1) the form did not reflect the 
patient’s wishes (e.g., patients did 
not remember discussing the form or 
didn’t agree with how it was filled 
its recommendation, and to provide 
this to the judge. 
It’s unclear whether an ethics 
committee was consulted in the 
McMath case. Perhaps this may have 
changed the course of events. Due 
to the media attention, the case was 
erroneously covered as a “right-to-
life” case and funds were donated to 
support care for Jahi’s body outside 
of the hospital at an undisclosed 
long-term care facility. The family 
reports taking time away from the 
media spotlight to “heal up.” One 
wonders whether the same could have 
been achieved with more effective 
communication and support for both 
family and staff. Clearly, more needs 
to be done to educate the public, the 
press, and health care providers about 
goals and limits of medicine at the end 
of life. 
Anita J. Tarzian, PhD, RN
MHECN Program Coordinator
Associate Professor, University of 
Maryland School of Nursing
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Death of a loved one is often met by anguish and demands from the bereaved to “do everything,” but 
sometimes it is human compassion and connection, rather than medical technology, that is required to help 
heal a broken heart.
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ELEVENTH HOUR
by K.D. Hayes
Reprinted with permission from Pulse—voices from the heart of medicine, which reveals the personal side of health care 
through weekly stories, poems and images. Subscribe at pulsevoices.org.
I didn't think that Walt should have 
the surgery. I thought it would cost 
too much suffering and money and 
ultimately lead to the same predictable 
outcome. I expressed concern that the 
medical community was pushing, even 
coercing, Walt to agree to surgery. 
My parents assured me that Walt 
understood the severity of his 
condition. He knew that he was a poor 
surgical candidate, that he might not 
survive the surgery, that he would 
suffer. 
And Walt said, "I want to live."
I disagreed with Walt's choice for 
another reason: I believed that it 
would thrust suffering upon his family 
members, who were also my loved 
ones.
His four children, who said he'd 
abused and molested them, would 
Uncle Walt died this morning. 
Finally.
I say "finally" because I believed 
this day would come four months 
ago, when he had emergency bypass 
surgery.
At the time, I didn't believe Walt 
would live; he was an ailing, seventy-
seven year-old man with severe 
pulmonary disease. When his heart 
started to hurt one Friday, his doctors 
told him, "With bypass surgery, you 
might live. Without it, you'll be dead 
before the weekend is over." 
Walt's oldest daughter and my 
parents, who were with him, told me 
about the doctors' recommendations.
 As a retired paramedic, I'd seen this 
scenario before—often enough to have 
a strong opinion, and my own advance 
directives.
suffer, dragged into advising and 
decision-making roles. My father 
would suffer because he loved his 
older brother deeply—despite my 
cousins' assertions and despite Walt's 
drinking away the first decades of 
his life, failing to find a successful 
career, and heading a family driven by 
dysfunction.
Walt had made our whole family 
suffer, and I didn't want him to cause 
more suffering. I felt angry with him. 
Over the years, his declarations of 
remorse had seemed insincere, his 
oblique admissions and apologies 
insufficient to heal his children's 
wounds. I felt he'd given them good 
reason to leave him. And though 
he had never mistreated me, I'd 
maintained a cool reserve.
In the end, Walt had the surgery—
out; (2) surrogates overrode MOLST 
orders; (3) clinicians defaulted to 
full cardio-pulmonary resuscitation 
(CPR) without discussing this with 
the patient, simply assuming that 
the patient would want to be a full 
code.); and (4) the MOLST form 
was inappropriately voided by a 
clinician (e.g., one clinician takes 
time to complete a MOLST form 
after discussion with a patient and 
another clinician completes a new 
MOLST form with no clear indication 
that the latter MOLST form reflects 
the patient’s wishes more accurately 
than the prior form). Other barriers to 
successful implementation included 
clinician errors interpreting the 
MOLST form, difficulty finding the 
most recently completed MOLST 
form, and concerns that the completed 
form was inconsistent with Maryland’s 
Health Care Decisions Act (e.g., 
by not recognizing the authorized 
decision maker for an incapacitated 
person, or overlooking procedures 
to certify medical conditions such as 
decisional incapacity, an end-stage 
or terminal condition or persistent 
vegetative state, or treatments 
considered medically ineffective). 
Perceived barriers to effective 
MOLST implementation include 
poor end-of-life communication 
skills among clinicians explaining 
MOLST to patients and families and 
clinicians completing the MOLST 
form, perceived lack of time among 
health care providers to complete the 
MOLST form, lack of buy-in from 
physicians and other key stakeholders 
regarding the MOLST process, 
clinicians not trusting the MOLST 
order form, and difficult timing of end-
of-life decision-making in acute care 
settings. Many identified a functioning 
state MOLST and advance directive 
registry as a necessary step to ensure 
successful MOLST implementation. 
Conference speakers presented 
strategies to address barriers to 
effective MOLST implementation, 
including communication skills and 
organizational approaches to effective 
MOLST adoption. Video-recordings of 
the conference sessions are available 
on MHECN’s website at http://www.
law.umaryland.edu/mhecn (click on 
Conferences).
MOLST 
Cont. from page 3
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and lived through it, although 
sometimes it hardly seemed living.
Essentially, his bypass saved his 
heart so that his lungs could kill 
him. He had a breathing tube in his 
windpipe and a feeding tube in his 
stomach; he lived through a week 
of "ICU psychosis," tormented by 
hallucinations. After he'd spent nearly 
a month in surgical intensive care, 
they moved him to an extended acute-
care hospital, then to a skilled-nursing 
facility.  
He had good days—a few. He taught 
his tired larynx to form words again. 
He progressed from sitting in a chair 
to standing to walking a few steps. 
Once, he walked all the way from his 
room to the lobby and back. He also 
had many bad days, when he couldn't 
even get out of bed. He suffered 
persistent urinary-tract and C. difficile 
infections. Whenever it seemed that 
Walt's body might give up the fight for 
life, the staff would ask Walt whether 
he wanted to be resuscitated. 
He always said, "I want to live." 
It was his decision; I don't think it 
would have been mine.
But what came of those days 
between the time I thought my 
uncle would die and the time, four 
months later, when he did die? Those 
expensive, painful days, dogged by 
fear and anxiety, when my cousins 
were spent and my parents exhausted, 
when Walt could have died but lived 
instead?
Walt found God. On the night before 
his surgery, the fear of death opened 
up a vulnerability in him, and he 
accepted a priest—and then God. He 
confessed. That night, with two of his 
four children by his side, he wept his 
confession.
My cousin recorded his father's 
words in a journal: "Forgive me for 
the abuse....I abused all of you. I wish 
I had been a better man." Walt asked 
his children for forgiveness, and they 
gave it. 
My cousin emailed this exchange to 
his brother and sisters, to his mother 
and aunts and uncles and cousins.
The next morning, huddling with my 
parents and cousins beside Walt, who 
lay unconscious after the operation, I 
did not know how to carry my anger.
But the months that followed gave 
my father more time to spend with his 
older brother. 
"Such a beautiful gift, this time," 
my father says now, even though those 
days also sucked away my parents' 
energy.
I doubt that Walt expected that his 
family would start healing--that his 
act of contrition would forge new 
bonds of obligation, responsibility and 
caring. 
But because the operation gave him 
those months after his "deathbed" 
confession, his children were able to 
tell him that they loved him; and their 
words resonated with a new truth. 
"We thanked him and told him he 
had given us a gift," my cousin wrote.
Several days after Walt's surgery, 
I stood by his bed and held his 
hand as he drifted into and out of 
consciousness.
His oldest daughter stood beside me. 
Whenever Walt was awake, he'd look 
at her and mouth the words "I love 
you." I felt I was watching them forge 
a new relationship. 
Walt's fractured, estranged family 
began reaching out, emailing or 
calling, traveling, reconnecting with 
each other—and even with Walt. I 
heard words of remorse, excruciating 
admissions, and gradually my anger 
subsided into awe.
I feel certain that Walt knew of the 
evolution that began in his family that 
dark night before his surgery, when he 
felt sure that he would die.
This morning, when Walt finally 
did die, he left behind a different 
life—and a different family. His oldest 
daughter stood in his hospital room, 
her boyfriend's arm through hers. Her 
two adult children hovered near their 
grandfather. My aunt stood at the foot 
of his bed. I knelt by the railing, my 
parents standing just behind me. 
I held Walt's hand and told him that 
it was okay to go—and that I loved 
him. Four months earlier, I'd thought 
the most pragmatic, least painful 
choice he could make would be not to 
fight for life. I'd thought it would be 
easier, kinder for everyone.
When is the right time to die?
I used to believe that I knew. 
Just after Walt's surgery, I made 
plans to fine-tune my own advance 
directives—to forbid intubation or 
stomach tubes.
 But I have yet to call my lawyer. 
I'm no longer so certain that choosing 
a quick, efficient death is selfless and 
honorable. 
Now I know that my choice to 
die won't be just about me. And that 
changes everything.
A writer and retired paramedic, K.D. 
Hayes has an MA in interdisciplinary 
studies and an MFA in creative 
writing. 
But what came of those days between the time I thought my uncle would die and the time, four months 
later, when he did die? Those expensive, painful days, dogged by fear and anxiety, when my cousins were 
spent and my parents exhausted, when Walt could have died but lived instead? Walt found God.
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ONE MARYLAND HOSPITAL’S APPROACH  
TO MEDICALLY INEFFECTIVE TREATMENT
The responsibility to preserve human life through medical science has moral limits. Extraordinary means that may not 
alleviate the underlying condition and may excessively burden the patient are not obligatory. Moral decisions about the 
extent of care should be made in terms of the benefit that may be offered and the burdens that may be imposed, assisted by 
the medical professional’s judgments and a person’s sense of what is appropriate. - Maryland Catholic Conference- End 
of Life, www.mdcathcon.org/endof life.
At the December 9, 2013 conference 
co-sponsored by MHECN and 
Harbor Hospital, Maryland Medical 
Orders for Life-sustaining Treatment 
(MOLST): A six month check-up, 
Lee Schwab, MD, FCCP, chair of 
the ethics committee at Holy Cross 
Hospital, presented his hospital’s 
approach to requests to provide 
medically ineffective treatment. One 
of the more common reasons for an 
ethics consult in Holy Cross’s adult 
inpatient population is moral distress 
among staff when negotiations over 
the care of dying patients breaks 
down and family members insist that 
their loved one continue to receive 
interventions that physicians have 
determined are medically ineffective 
in achieving the goals of care. Reasons 
for cases like these are familiar to 
ethics committee members: there is 
an increasing number of terminally 
ill patients admitted to intensive 
care units without appropriate prior 
end-of-life planning; physicians of 
diverse cultural origins let patients/
family members choose which 
medical interventions to pursue 
without identifying goals of care and 
without restrictions on treatments 
unlikely to achieve the goals of care; 
physicians view their prime ethical 
duty as advocating for the individual 
patient rather than stewardship to 
the institution and the community; 
physicians and patients alike shy away 
from open discussions about death, 
dying, and goals of care at the end of 
life; and physicians tend to acquiesce 
to patient/family demands for fear 
of the time and expense involved if 
they get sued. There was (and still 
is) misperception among physicians 
and members of the community that 
patients/surrogates have the right to 
demand all medical interventions.
Until recently, physicians have had 
little incentive to concern themselves 
with limiting non-beneficial treatment 
because they have been reimbursed 
for the additional acute care services 
provided to dying patients. The 
hospital, on the other hand, places 
itself in financial jeopardy when 
resource-intensive, non-reimbursable, 
non-beneficial treatments are provided 
on demand. Attention to financial 
sustainability is often downplayed in 
clinical ethics due to concerns that 
ethicists and clinicians should not 
“ration at the bedside.” However, 
there is growing recognition that 
stewardship of finite medical resources 
is an important component of ethical 
analysis that should not be excluded 
in ethics case consultations. While 
withholding or withdrawing medically 
ineffective treatment can be justified 
for reasons other than resource 
stewardship (for example, if it is not in 
the patient’s best interests or consistent 
with his or her wishes), in some cases 
where a surrogate demands medical 
interventions for a non-communicative 
dying patient that won’t achieve 
established goals, clinicians and 
ethicists should recognize justice 
obligations that are based on 
responsible allocation of medical 
resources. These obligations must be 
balanced by other ethical principles, 
such as the duty to minimize regrets 
and support the grieving process 
of bereaved loved ones. Thus, how 
institutions approach withholding or 
withdrawing non-beneficial treatments 
is critical to avoid the pendulum 
swinging from over-treatment at the 
end of life to under-treatment. 
Holy Cross Hospital addressed this 
challenge at the organizational level. 
First, the ethics committee obtained 
feedback from staff revealing that 
physicians, in particular, did not 
view the ethics consultation process 
as useful in disputes about medical 
futility. Physicians perceived that they 
were taking most of the risk when 
they proceeded with certifications 
to withhold or withdraw medically 
ineffective interventions from a 
patient. Many physicians were 
unaware or unconvinced that an ethics 
consultation provided them with 
liability protection. 
The ethics committee proceeded to 
address this by obtaining support from 
By a show of hands, attendees at the December 9, 2013 MOLST conference supported a process of 
establishing a hospital policy and procedure “community standard” in the state to withhold or withdraw 
medically ineffective treatment without a patient/surrogate’s consent. This could include clarifying some of 
the terms in Maryland’s HCDA, such as the definition of death being “imminent,” a patient being “terminal,” 
and what a “reasonable time” is to arrange transfer. It might also address ways to ensure fairness, such as 
referral of such cases for ethics consultation.
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senior leadership and hospital counsel 
to integrate ethical principles with 
the process outlined in the Maryland 
Health Care Decisions Act (HCDA). 
They created a facility-wide policy 
and process to address determinations 
of medically ineffective treatment. Dr. 
Schwab underscored the importance 
of this step: all staff—physicians 
in particular—must believe that the 
hospital is fully supporting them. 
At Holy Cross Hospital, they have 
found that physician-to-physician 
communication is an important 
component of the process. Another 
realization involved the greater 
comfort level of staff and patients’ 
family members regarding withholding 
non-beneficial treatment rather than 
withdrawing treatment. While in ethics 
no moral distinction is made between 
the two, the reality that these acts feel 
different has been incorporated into 
Holy Cross’s process by allowing 
for “no escalation of treatment” 
decisions in some cases, rather than 
stopping all life support at once. 
Although ideologically imperfect, Dr. 
Schwab views this as a worthwhile 
compromise in the efforts to balance 
stewardship with compassion toward 
the emotional needs of grieving loved 
ones.
Another important aspect of Holy 
Cross’s process is absolute clarity 
that physicians, rather than ethics 
committee members, determine that 
a patient is in a terminal, end-stage, 
or vegetative condition, or that a 
particular intervention is medically 
ineffective. The ethics consultants 
may advise that additional medical 
consultation (e.g., neurology) confirm 
a treating physician’s determination, 
but those requesting an ethics 
consultation need to understand that 
the practice of medicine resides with 
clinicians. 
HOLY CROSS HOSPITAL’S PROCESS FOR WITHHOLDING/WITHDRAWING 
MEDICALLY INEFFECTIVE TREATMENT 
Step 1 – Data Collection 
An ethics committee member (at Holy Cross Hospital this is often a physician, to allow direct physician-to-physician 
communication) collects relevant information from the medical chart and from stakeholders, visits the patient, 
reviews any advance directive or MOLST documents, identifies a surrogate decision-maker (if the patient lacks 
decision-making capacity), and reviews certifications for capacity, condition, and medically ineffective treatment. If 
there are no certifications yet completed, the consultant asks the physician whether he or she is willing to complete 
certifications if appropriate. The consultant may convene a meeting of the ethics committee if needed. A palliative 
care consultation may be recommended if not yet done. Recommendations are made and a written consultation note 
is placed on the chart, after first being reviewed by the Vice President of Mission Services, Vice President of Spiritual 
Care and Ethics, and Risk Management. 
Step 2 – Negotiate Goals of Care 
An ethics consultation regarding withholding or withdrawing medically ineffective treatment occurs when a patient 
or surrogate disagrees with the physician’s decision to withhold or withdraw treatment. Thus, an attempt is made 
to mediate this conflict by negotiating achievable goals of care, sometimes by facilitating a family meeting. Those 
involved often include the palliative care team, the patient’s own primary care physician, chaplaincy, and the patient’s 
own clergy. If, based on negotiations surrounding goals of care for the patient, the patient/surrogate agrees to withhold 
or withdraw medically ineffective treatment, the ethics consultation is complete. If the patient/family continues to 
insist that medically ineffective interventions be provided, they are informed that certain treatments may be withheld 
or withdrawn despite their wishes using the process defined in Maryland’s HCDA, including the option of transfer. 
Step 3 – Implementation 
At this point, all appropriate certifications are completed (e.g., patient incapacity; patient condition, i.e., terminal 
condition, end-stage condition, vegetative state, or medically ineffective treatment). Holy Cross has developed 
forms to use for these certifications. The patient or surrogate is informed of treatments to be withheld or withdrawn 
and is given a reasonable period of time, usually one week, to find a physician and facility willing to provide those 
treatments. All disputed treatments are provided during that time. Holy Cross will facilitate transfer if one is found. A 
letter from Senior Management is given to the patient or surrogate explaining this. If an alternative facility cannot be 
found, orders to withhold/withdraw medically ineffective treatment(s) are written, the patient or surrogate is informed, 
and the disputed treatments are withheld or withdrawn, with appropriate spiritual and palliative care provided.
Cont. on page 8
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Components of Holy Cross’s 
process that Dr. Schwab identified 
as being particularly instrumental in 
its success include having specific 
wording in ethics consultation notes 
that physicians find supportive of 
medically ineffective treatment 
determinations, use of a standardized 
Certification of Medically Ineffective 
Treatment form, and administrative 
support in the form of a letter given 
to the patient’s surrogate signed by 
a member of Senior Management, 
affirming the physician’s plan to 
withhold/withdraw treatment by a 
given date unless transfer can be 
arranged. 
Dr. Schwab noted that this process 
has been helpful when the surrogate 
feels overburdened by having to make 
decisions about whether their loved 
one lives or dies, or when a surrogate 
feels pressured by family or culture 
to choose aggressive life-prolonging 
treatments for the patient. Having 
the physician make the decision may 
remove the burden from the surrogate. 
It has also been helpful in some cases 
where there is no surrogate and the 
patient is appropriate for “comfort care 
only,” as it precludes going to court to 
have a guardian appointed. However, 
staff need to be prepared to handle 
feelings of anger and resentment 
among some 
family members 
who disagree 
with decisions 
to withhold 
or withdraw 
non-beneficial 
interventions from 
their loved one.
While Maryland’s 
HCDA does not 
specify a period 
of time to await 
transfer if a 
surrogate disagrees 
with a decision 
to withhold or withdraw medically 
ineffective treatment, Holy Cross 
typically allows a seven day period 
for patients who are hemodynamically 
stable (i.e., if no transfer can be 
arranged within that time period, 
the medically ineffective treatment 
will be withheld or withdrawn after 
seven days). For patients who are 
actively dying and hemodynamically 
unstable, physicians may determine 
that transfer is not an option and 
institute “no escalation of treatment” 
upon informing the surrogate of 
this decision. During the discussion 
period following Dr. Schwab’s talk 
at the December 9, 2013 MOLST 
conference, Jack Schwartz (formerly 
with the Maryland State Attorney 
General’s office) opined that he 
viewed this as consistent with the 
HCDA because the reference to 
“pending transfer” in Maryland’s 
HCDA should be interpreted as 
awaiting a planned transfer, which 
wouldn’t apply in the case of a patient 
with no available transfer options.
To view Dr. Schwab’s presentation, 
visit MHECN’s website at http://www.
law.umaryland.edu/mhecn and click 
on “Conferences.”
Medically Ineffective Treatment 
Cont. from page 7
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an 
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit 
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the 
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify 
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to  
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey 
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
NOTE: A Maryland physician was 
involved in the case below while 
working in another state. The 
hospital's ethics committee was not 
involved. Details have been changed 
to protect confidentiality.
Antonia is a 34 year old woman 
who is 11 weeks pregnant with twins 
and hospitalized for complications 
of pregnancy. The amniotic sac for 
Twin A has ruptured, but the sac for 
Twin B is intact. Based on available 
outcomes literature, Twin A is not 
expected to survive. Thus, only Twin 
B is being monitored (via ultrasound 
once per shift). Antonia is put on 
inpatient bedrest to minimize the risk 
that Twin B’s sac will prematurely 
rupture. A neonatal intensive care 
unit (NICU) fellow is consulted on 
the case. She proposes that starting 
at 24 weeks, the team could begin 
monitoring Twin A and, if either 
twin showed signs of distress, could 
deliver both twins early. Antonia, 
an undocumented immigrant from 
Mexico who does not speak English, 
is a devout Catholic. She considers 
that not intervening to try to save 
Twin A would be like “killing” the 
baby, and that even though an early 
delivery would threaten the life of 
either twin, she must try to save them 
both. She requests that both twins be 
monitored starting at 24 weeks, with 
the expectation that they be delivered 
via cesarean section if either show 
signs of distress. The neonatologists, 
while concerned that there isn’t really 
a reasonable chance that they can save 
Twin A, feel that the team made this 
promise to Antonia and they can’t 
go back on it. A NICU resident calls 
a member of the ethics consultation 
service to discuss the ethics of this 
situation. She reasons that since it’s 
almost a certainty that Twin A will die 
regardless of any intervention, there 
is no benefit to Twin A from the early 
delivery, but clear harm to Twin B.
RESPONSE FROM A 
NEONATOLOGIST & ETHICS 
COMMITTEE MEMBER
The past two decades have seen 
a near doubling in rates of multiple 
births across the U.S. and many 
European countries (Kulkarni, 2013; 
Boyle, 2013). Some although not all 
of this increase is the result of growing 
use of assisted reproduction—
technologies with inherent risks of 
multiple gestation. Multiple gestations 
have higher rates of congenital 
anomalies and premature birth than 
do singleton pregnancies. Usually 
only one fetus will be affected by the 
anomaly or premature rupture of the 
amniotic sac. Hence, it is increasingly 
common that parents and clinicians 
face decisions about how to balance 
competing interests of the affected 
fetus and the unaffected fetus(es)—
and how to balance these with the 
interests of the mother. The literature 
in perinatal and pediatric bioethics 
lags behind this clinical trend, with 
most discussions of prenatal decision-
making limited to maternal-fetal 
conflicts in singleton pregnancies.  
In the case presented here, 
premature rupture of the amniotic sac 
for Twin A occurred at 11 weeks, and 
we assume there is minimal residual 
amniotic fluid. Antonia does not 
appear to be in labor, so the pregnancy 
could continue for days, weeks, or 
months. Amniotic fluid is critically 
important to fetal lung development; 
without adequate amniotic fluid in the 
second trimester, fetal lung formation 
is severely limited. The overwhelming 
majority of such infants will die before 
or soon after birth. Rarely, a ruptured 
amniotic sac can reseal and amniotic 
fluid reaccumulate; we are not told 
that this occurred for Antonia. Some 
small studies suggest that repeated 
fluid infusions into the uterus until 
birth can permit neonatal survival 
for a minority (Locatelli, 2000). For 
Antonia, this therapy would be yet 
another intervention with questionable 
benefit for Twin A and risk for Twin B. 
In sum, there are no interventions to 
give Twin A even a modest chance of 
survival.
Neither of Antonia’s twins is viable 
at 11 weeks, but her pregnancy could 
continue for months. In general, 
prior to 23 weeks gestation, neonatal 
survival is extremely rare and so 
resuscitation is typically not offered 
by U.S. clinicians. After 25 weeks, 
neonatal survival is greater than 
50% and so most clinicians feel that 
resuscitation should be attempted. 
Between 23-25 weeks, neonatal 
survival is low but possible, so the 
standard of care is to allow families 
to participate in decisions about 
resuscitation based on their goals 
and values. These management 
guidelines must be amended when 
the fetus has another condition which 
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impacts morbidity or mortality—
such as Twin A’s abnormal lung 
development. There are no objective 
data to guide resuscitation decisions 
in these situations. If Antonia went 
into spontaneous labor at 24 weeks, 
and greatly desires resuscitation for 
both twins, it is likely that some or 
most of the neonatologists would 
have complied with that request. 
Twin A may not survive resuscitation, 
but in the case of spontaneous labor, 
resuscitation of Twin A does not 
directly harm Twin B. 
The issue in this case that most 
clearly pits the interests of Twin 
A, Twin B, and the mother against 
each other is the issue of premature 
cesarean section. Cesarean section 
after premature rupture of membranes 
can improve survival if fetal health is 
deteriorating. Prior to 24 weeks, the 
maternal risk from cesarean section is 
thought to be higher than the chances 
for neonatal survival, hence surgical 
delivery is usually only offered after 
24 weeks. In a multiple gestation, 
where only one fetal sac has ruptured, 
premature cesarean section to optimize 
survival of that fetus necessarily 
imposes the risks of prematurity on 
the other fetus(es), who may not have 
delivered until term. For Antonia, 
should both fetuses survive beyond 24 
weeks, Twin A will be the most likely 
to demonstrate fetal distress.   
This case touches on the important 
question of whether it is permissible 
for a pregnant woman to place a 
healthy fetus at risk of death in 
an attempt to save a fetus who is 
unlikely to survive (Chervenak, 
2013). Unfortunately, this option 
was presented as a valid choice to 
Antonia before team consensus 
about that option was achieved. 
Predictably, in the face of an ethically 
complex medical case, there are 
divergent opinions among medical 
team members about what options 
are permissible. Ideally, team 
members will convene to discuss and 
reach consensus about permissible 
and recommended management 
plans before presenting options 
to the patient. Interdisciplinary 
team members, trainees, and ethics 
consultants should all be invited to 
engage in this process. Clearly some 
clinicians in this case do not agree 
with the option of cesarean section to 
save Twin A. When a controversial 
management plan is offered to a 
patient without team consensus, 
iatrogenic harm can occur. 
Much is unknown about Antonia, the 
circumstances of her pregnancy, her 
social supports, or her Catholic beliefs. 
Few pregnant women are prepared for 
the possibility of extremely premature 
labor and months of bedrest with 
the impact on jobs, childcare, and 
finances. Antonia is an undocumented 
immigrant from Mexico, and is 
likely to have experienced economic 
insecurity, limited access to healthcare 
including prenatal care, and multiple 
social stressors. Identifying persons 
who can partner with her in these 
difficult decisions is crucial because 
she may lack cultural context for 
sharing serious medical decisions. 
Her Catholic beliefs appear to be 
important to her; involving a hospital 
or community priest may reduce 
Antonia’s suffering and can help 
navigate discussions about hope 
and quality of life. Antonia does not 
speak English, which may weaken 
understanding between the patient and 
the medical team.   
A significant question about 
communication in this case revolves 
around the issue of what clinicians 
have told Antonia will happen to 
or for Twin A if resuscitation is not 
attempted. Too often this decision is 
posed as “do nothing,” suggesting 
that clinicians will abandon the infant 
after birth. A more skilled approach 
will emphasize the actions that can 
be taken to minimize suffering and 
maximize comfort, bonding, and 
memory making, so that the infant’s 
life is filled with love and gentleness. 
Perinatal palliative care could begin 
from the moment of diagnosis, from 
the moment that Antonia was admitted 
with pregnancy complications. 
Irrespective of the pregnancy 
decisions or outcomes, palliative care 
can provide support and continuity and 
can ease suffering. These services are 
increasingly available though inpatient 
consultation or through relationships 
with local hospices.
Renee Boss, MD, MHS
Assistant Professor, 
Division of Neonatology
Johns Hopkins School of Medicine
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COMMENTS FROM A 
CATHOLIC BIOETHICIST
Antonia’s dilemma sheds light 
on three important facets of clinical 
bioethics, including the benefit of 
having faith-trained ethicists, the 
ability to end an error chain before 
the error occurs, and the necessity to 
correct mistakes in a timely manner.
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This case presents a complex, 
controversial ethical situation and 
Antonia’s devout religious beliefs 
are truly admirable. It should be 
noted, though, that although Antonia 
believes attempting to save both 
twins is mandatory according to 
her Catholic faith, there are in fact 
provisions in Catholic doctrine that 
make it permissible to jeopardize the 
health of one twin for clear benefit to 
the other. It is certainly true that every 
human being has a fundamental right 
to life and that Catholics believe in 
the dignity of life from conception 
to natural death, but it is equally true 
that the ethical principle of double 
effect offers an acceptable solution to 
this complicated situation. Originally 
outlined by St. Thomas Aquinas in 
his work Summa Theologica, this 
principle offers an understanding of 
actions that have both an intended 
good effect and an unintended evil 
effect. The principle’s concept—that 
foreseen harm can be done as long 
as the harm is unintended and the 
intended good is commensurable—
corresponds to the circumstances 
of this case very well. Indeed, the 
good of saving Twin A’s life is surely 
proportionate to losing Twin B, as sad 
and unfortunate as that outcome is 
(Paris & Elias-Jones, 2001). Without 
knowing more specifics of the case, 
but assuming nothing harmful was 
intentionally or directly done to 
Twin A, application of the principle 
of double effect instructs us that 
delivering Twin B at 25 weeks or 
soon thereafter (as warranted by the 
ultrasound monitoring), even with 
the probable demise of Twin A, is 
wholly permissible in accordance with 
Catholic theology (Annas, 2007).
In addition to the principle of double 
effect, the principle of proportionality 
must also be considered. The fact of 
the matter is that early delivery is 
disproportional for both Twin A and 
Twin B. The advertised and requested 
treatment is 
disproportional 
for Twin A 
because it is not 
likely to help, 
is very invasive 
and expensive, 
and, more 
abstractly, would 
not result in a 
‘good’ death. 
Similarly, it is 
disproportional 
for Twin B 
because it carries extreme risk (so 
much so that the benefits do not 
outweigh the risks) and is equally as 
invasive and expensive as for Twin 
A.  In this case study, an ethicist with 
a background in Catholic healthcare 
ethics would have been immensely 
helpful to correct the inaccuracies 
in Antonia’s perception of Catholic 
bioethics. In this way, faith-trained 
ethicists have the capability (and 
moral obligation) to correct a patient’s 
misunderstanding by explaining 
the medical treatments available to 
the patient and to walk through the 
morality of each according to the 
specific faith’s doctrine.
Although not an ethical principle, 
another major theme to extract from 
this case study is the responsibility 
of health care teams to recognize 
potential mistakes before they occur 
since the Harvard Medical Practice 
study concluded that 90% of medical 
errors are preventable (Wolf & 
Hughes, 2010). The necessity to 
correct mistakes in a timely manner 
is a concept that seems intuitively 
simple and somewhat obvious, but 
can be surprisingly difficult in clinical 
situations. Admitting a mistake is 
never easy, of course, and in the case 
of medical mistakes, is fraught with 
worry about lawsuits. Nevertheless, 
mistakes that could harm a patient 
must be counteracted and negated as 
soon as they are recognized. Indeed, 
mistakes simply never get better 
with time and an empty promise of a 
medical treatment is better than the 
loss of a life.
Recognition of the mistake becomes 
increasingly difficult with larger 
healthcare teams. Coming from a 
military background, I apply the term 
“error chain” to this problem. That is, 
each person involved with the care of 
Antonia and her twins has the ability 
to halt the series of decisions before it 
results in a medical error. Since each 
decision might be small in nature and 
seemingly insignificant unless taken 
in aggregate with the other small 
decisions, error chains are notoriously 
difficult to identify. Here, in this case, 
the doctors, nurses, family members, 
on-call ethicist, and ethics committee 
members all had an opportunity to 
identify the mistake of suggesting both 
twins could be monitored starting at 25 
weeks. In other words, they could have 
corrected that promise either before 
the patient requested monitoring or 
before the healthcare team assented to 
the monitoring, and therefore before 
anyone ultimately inflicted harm to 
Twin B.
The expanding number of people 
involved in many of these ethically 
challenging cases begs the question, 
“Who is best suited for identifying 
the mistake?”  Arguably, this 
responsibility falls particularly on 
the shoulders of the ethicist because 
Cont. on page 12
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FEBRUARY
24 (12:15-1:30P) 
Disparate Views on the End of Life. Bioethics seminar speaker Sarah Shannon, PhD, RN, sponsored by The Johns 
Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. For more information, visit 
http://www.bioethicsinstitute.org/.
14 (4-8P) 
Bioethics Colloquium with Dave Wendler, sponsored by the Center for Bioethics, New York University, New 
York, NY. For location & further information, and to RSVP, visit http://bioethics.as.nyu.edu/page/events. 
27 
Do Emotions Derail Rationality? Webinar discussing article “When concretized emotional-belief complexes derail 
decision-making capacity,” in Bioethics, 2012, 26(2), 108-16, with author Jodi Halpern, MD, PhD. Sponsored by 
the American Journal of Bioethics. For time and registration information, contact cmbc@cmh.edu, call 816-701-
5285, or visit https://cmhbioethicswebex.com/. 
MARCH 
6 
The Culture of Dysthanasia. Webinar discussing article “The cuture of dysthanasia: attempting CPR in terminally 
ill children,” in Pediatrics, 2013, 131(3), 572-80, with co-author Jonna Clark, MD, MA. Sponsored by the 
American Journal of Bioethics. For time and registration information, contact cmbc@cmh.edu, call 816-701-
5285, or visit https://cmhbioethicswebex.com/. 
7 (4-7P) 
Bioethics Colloquium with Dan Brock, sponsored by the Center for Bioethics, New York University, New York, 
NY. For location & further information, and to RSVP, visit http://bioethics.as.nyu.edu/page/events.
CALENDAR OF EVENTS
the ethicist’s fresh eyes approach 
the case without being intricately or 
emotionally involved with the day-to-
day care of the patient. They bring to 
the problem a top-down rather than 
a  bottom-up perspective, and this 
change in thinking permits an opening 
that might be closed to others. In 
order for ethicists to capitalize on that 
opening, they should never become 
complacent consulting on cases. 
As ethicists trained to analyze the 
facts of the case and offer a decision 
best for the patient based on the 
circumstances at hand, it is imperative 
that their judgment is not excessively 
influenced by the information they 
gather from others on the health care 
teams. Doing so will increase the 
chance of glossing over the error. 
Instead, they must ask pertinent 
questions and examine the entirety 
of the case for themselves whenever 
possible so that the succession of 
small decisions is seen as a whole and 
the medical mistake is more easily 
caught. Despite the physician actually 
disclosing the error to the patient, the 
ethicist plays an important role in the 
process of identifying the error and 
must be firm when discussing his or 
her recommendations with others. To 
be clear, this certainly does not clear 
other healthcare team members of 
all responsibility, but instead merely 
lessens the degree of expectation 
that they would be able to catch the 
error. It also highlights the necessity 
of encouraging open communication 
among all healthcare team members so 
that anyone who discovers the mistake 
feels comfortable enough to bring it to 
the attention of the physician.
Kathleen M. Gilpin
PhD Candidate for Neuroscience
University of Maryland School 
of Medicine
Ethics Consultant Intern 
Anne Arundel Medical Center
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7-9 
Responding to the Limits and Possibilities of the Body, 3rd Annual Conference on Medicine & Religion. Hyatt 
Chicago Magnificent Mile, Chicago, IL. For more information, visit http://www.medicineandreligion.com/
registration.html.
8 
Difficult Conversations in Healthcare: Teaching and Practice, sponsored by the Institute for Professionalism & 
Ethical Practice, Boston Children’s Hospital and Harvard Medical School. Waltham, MA. Course repeats on May 
17 and June 7. For more information, visit http://www.hms-cme.net/3424265/3424265_emailindex2.html. 
10 (12:15-1:30P) 
Dignity for Patients in the ICU: A Conceptual Model. Bioethics seminar speaker Leslie Meltzer-Henry, JD, 
sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. For 
more information, visit http://www.bioethicsinstitute.org/.
19 
Dangerousness & Involuntary Treatment: An Applied Ethics Workshop, sponsored by the University of 
Pennsylvania’s Department of Medical Ethics & Health Policy, Claudia Cohen Hall, Terrace Room, Philadelphia, 
PA. For more information, visit medicalethics.med.upenn.edu. 
20-21 
Embracing Change: Balancing Innovation and Our Humanity. Health Care Ethics Consortium’s Annual 
Conference. Sponsored by Emory University’s Center for Ethics and the Health Care Ethics Consortium of 
Georgia (HCECG). Atlanta, Georgia. For more information, visit www.hcecg.org .
APRIL
1-4 
Public Health Ethics Intensive, sponsored by the National Center for Bioethics in Research and Health Care 
located at Tuskegee University. For more information, visit http://www.tuskegee.edu/about_us/centers_of_
excellence/bioethics_center.aspx.
11 (4:30-7P) 
Bioethics Colloquium with Maggie Little, sponsored by the Center for Bioethics, New York University, New 
York, NY. For location & further information, and to RSVP, visit http://bioethics.as.nyu.edu/page/events.
14 (12:15-1:30P) 
Moving Beyond Futility: Resolving intractable clinician-family disputes in patients with advanced critical illness. 
Bioethics seminar speaker Doug White, MD, sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 
N. Wolfe Street, Baltimore, MD, W3008. For more information, visit http://www.bioethicsinstitute.org/.
23 
Ethical Dilemmas in the Practice of Obstetrics, Gynecology & Reproductive Medicine, Sponsored by the 
Cleveland Clinic, Cleveland, Ohio. For more information, visit http://www.clevelandclinicmeded.com/live/
courses/2014/obgyn14/default.asp.
24-25 
Ethics Problem Solving and Consultation: The Mayo Approach. Sponsored by The Mayo Clinic, Rochester, MN. 
For more information, visit http://www.mayo.edu/cme/special-topics-in-health-care-2014r571.
25-26 
Symposium on Ethics and Mental Health, Marietta, OH. For more information, contact akp004@marietta.edu. 
Cont. on page 14
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CALENDAR OF EVENTS (cont'd)
APRIL (cont'd)
28 (12:15-1:30P) 
The Ethics of Personal Responsibility. Bioethics seminar speakers Diane Hoffman, JD, MS & Janyne Althaus, 
MD, sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, 
W3008. For more information, visit http://www.bioethicsinstitute.org/.
MAY
1-2 
New Stressors and Solutions in Health Care Ethics, sponsored by the Colorado Healthcare Ethics Forum (CHEF), 
Thornton, CO. For more information, visit http://coloradoethicsforum.org/.  
8-10 
Ways and Means: Teaching Professionalism Across the Health Care Spectrum, 2nd annual meeting of the 
Academy for Professionalism in Health Care. Hilton Garden Inn, Chicago, IL. For more information, visit http://
academy-professionalism.org/index_/2014_Annual_Meeting.html.
12 (12:15-1:30P) 
Berman Bioethics Seminar speaker Brad Malin, PhD (biomedical informatics), sponsored by The Johns Hopkins 
Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. For more information, visit http://
www.bioethicsinstitute.org/.
17 
Difficult Conversations in Healthcare: Teaching and Practice, sponsored by the Institute for Professionalism & 
Ethical Practice, Boston Children’s Hospital and Harvard Medical School. Waltham, MA. Course repeats on June 
7. For more information, visit http://www.hms-cme.net/3424265/3424265_emailindex2.html. 
19-20 (and June 16-17) 
4 Day Intensive Course in Bioethics Consultation Skills, sponsored by Montefiore-Einstein Center for Bioethics, 
New York, NY. Pre-requisite Montefiore-Einstein Certificate Program in Bioethics and Medical Humanities or 
permission of instructor. For more information, visit http://www.einstein.yu.edu/masters-in-bioethics.
25-30 
Medical Humanities: Clinical & Pedagogical Perspectives, sponsored by the Doctors Kienle Center for 
Humanistic Medicine, Penn State College of Medicine, Hershey, PA. For more information, contact 
kienlecenter@hmc.psu.edu or visit http://www2.med.psu.edu/humanities/kienle-symposium. 
26 (12:15-1:30P) 
Berman Bioethics Seminar, sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, 
Baltimore, MD, W3008. For speaker information and topic, visit http://www.bioethicsinstitute.org/.
28-31 
The 25th Annual Canadian Bioethics Society Conference: Looking Back; Looking Forward. Renaissance 
Vancouver Harbourside Hotel, Vancouver, CA. For more information, visit www.cbs-scb2014.ca.
JUNE 
2-6 
Intensive Bioethics Course sponsored by the Kennedy Institute of Ethics, Georgetown, MD. For more 
information, visit http://kennedyinstitute.georgetown.edu/programs/ibc.cfm .
7 
Difficult Conversations in Healthcare: Teaching and Practice, sponsored by the Institute for Professionalism & 
Ethical Practice, Boston Children’s Hospital and Harvard Medical School. Waltham, MA. For more information, 
visit http://www.hms-cme.net/3424265/3424265_emailindex2.html. 
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The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by 
the Law and Health Care Program at the University of Maryland Francis King Carey School of Law. The purpose 
of MHECN is to facilitate and enhance ethical reflection in all aspects of decision making in health care settings 
by supporting and providing informational and educational resources to ethics committees serving health care 
institutions in the state of Maryland. The Network attempts to achieve this goal by:
   • Serving as a resource to ethics committees as they investigate  
 ethical dilemmas within their institution and as they strive to assist  
 their institution act consistently with its mission statement;
   • Fostering communication and information sharing among Network  
      members;
   • Providing educational programs for ethics committee members, other 
      healthcare providers, and members of the general public on ethical  
 issues in health care; and
   • Conducting research to improve the functioning of ethics committees 
 and ultimately the care of patients in Maryland.
MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from 
affiliate members who provide additional financial support.
8-27 
Bioethics Boot Camp at the University of Pensylvania, sponsored by the University of Pennsylvania’s 
Department of Medical Ethics & Health Policy. Applications due February 17. For more information, visit 
medicalethics.med.upenn.edu. 
9 (12:15-1:30P) 
Berman Bioethics Seminar, Berman Bioethics Seminar speaker Brad Malin, PhD (biomedical informatics), 
sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. 
For more information, visit http://www.bioethicsinstitute.org/.
23 (12:15-1:30P) 
Berman Bioethics Seminar, sponsored Berman Bioethics Seminar, sponsored by The Johns Hopkins Berman 
Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. For speaker information and topic, visit 
http://www.bioethicsinstitute.org/.
26-28 
Comics & Medicine: From Private Lives to Public Health. Sponsored by The Johns Hopkins University 
School of Medicine Department of Art as Applied to Medicine in collaboration with Graphic Medicine, at the 
Johns Hopkins Medical Campus, Baltimore, MD. For more information, visit http://www.graphicmedicine.
org/comics-and-medicine-conferences/2014-baltimore-conference/.
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